U.S. markets open in 3 hours 49 minutes

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
14.27+0.13 (+0.92%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/20/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
1.03B1.26B1.32B1.27B1.15B
Enterprise Value 3
906.56M1.17B1.28B1.27B1.16B
Trailing P/E
8.738.447.718.9313.19
Forward P/E 1
32.4712.3812.6910.457.54
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
2.482.842.973.063.33
Price/Book (mrq)
3.684.936.198.1010.93
Enterprise Value/Revenue 3
1.9110.6011.259.379.99
Enterprise Value/EBITDA 7
5.6767.7837.0819.1227.94

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3-13.36%
S&P500 52-Week Change 348.72%
52 Week High 322.22
52 Week Low 313.53
50-Day Moving Average 314.97
200-Day Moving Average 317.11

Share Statistics

Avg Vol (3 month) 31.34M
Avg Vol (10 day) 3901.35k
Shares Outstanding 573.11M
Implied Shares Outstanding 6N/A
Float 59.96M
% Held by Insiders 11.35%
% Held by Institutions 1124.95%
Shares Short (Mar 30, 2021) 413.84M
Short Ratio (Mar 30, 2021) 410.96
Short % of Float (Mar 30, 2021) 427.25%
Short % of Shares Outstanding (Mar 30, 2021) 418.94%
Shares Short (prior month Feb 25, 2021) 413.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 27.79%
Operating Margin (ttm)32.85%

Management Effectiveness

Return on Assets (ttm)15.62%
Return on Equity (ttm)68.49%

Income Statement

Revenue (ttm)475.82M
Revenue Per Share (ttm)6.66
Quarterly Revenue Growth (yoy)-10.80%
Gross Profit (ttm)295.4M
EBITDA 159.21M
Net Income Avi to Common (ttm)132.24M
Diluted EPS (ttm)1.62
Quarterly Earnings Growth (yoy)-75.30%

Balance Sheet

Total Cash (mrq)541.16M
Total Cash Per Share (mrq)7.43
Total Debt (mrq)417.1M
Total Debt/Equity (mrq)148.45
Current Ratio (mrq)5.27
Book Value Per Share (mrq)3.88

Cash Flow Statement

Operating Cash Flow (ttm)154.14M
Levered Free Cash Flow (ttm)83.04M